glp-1 obesity drug news today october 16 2025 Compound versions of drugs for weight loss halted by FDA 2024 was a record year

67,68 Still, the presence of GLP-1 RA-specific psychiatric adverse events that may also be related to drug intolerance requires the development of a strategy to overcome this barrier for the better implementation of GLP-1RA therapy

These hormones are released by the gut in response to food intake and play crucial roles in glucose regulation

Retatrutide and other newer GLP-1 agonists: no lactation data yet The GLP-1 landscape is expanding rapidly

A total of 86 articles were retrieved

S3)):S434S442

* While weight loss can be challenging, working with a healthcare provider or diabetes educator to develop a plan can help you reach your body weight goals